+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Phosphoramidite Market by Type, Purity Level, End-User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5847032
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Phosphoramidite Market grew from USD 1.20 billion in 2023 to USD 1.28 billion in 2024. It is expected to continue growing at a CAGR of 7.29%, reaching USD 1.97 billion by 2030.

Phosphoramidites are essential chemical compounds predominantly used in the synthesis of oligonucleotides, critical for developing genetic testing tools, therapeutics, and research applications. Their necessity stems from the growing demand for personalized medicine, genomic sequencing, and research in molecular biology, which have expanded their applications to sectors like healthcare, diagnostics, biotechnology, and pharmaceuticals. The global phosphoramidite market's growth is significantly driven by advancements in genetic sequencing technologies, increased funding for genomic research, and the rising prevalence of genetic disorders necessitating effective diagnostic solutions. Key growth influencers include technological innovations in synthesis procedures, an increase in R&D investments, and the ongoing integration of advanced genetic tools in clinical settings. The market also presents opportunities in the burgeoning field of CRISPR and gene editing technologies, with phosphoramidites playing a crucial role in the development of guide RNA synthesis. However, the market faces limitations such as stringent regulatory requirements for nucleic acid-based therapies, high synthesis costs, and challenges in raw material procurement impacting production scalability. These factors may hinder market expansion, necessitating strategic measures to mitigate their effects. To navigate these challenges, innovation in cost-effective synthesis methods and improved stability of phosphoramidites can offer competitive advantages. Overcoming technical constraints in oligonucleotide delivery mechanisms and enhancing their bioavailability are potential areas of research yielding significant business growth. The phosphoramidite market remains dynamic, characterized by rapid technological evolution and competitive intensity among key players striving for patentable innovations. Businesses looking to capitalize on this growth should focus on collaborations with academic institutions, investment in cutting-edge synthesis technologies, and expanding application scopes of phosphoramidites to untapped market segments such as agriculture and environmental sciences. By doing so, they can harness the potential of this evolving market while addressing its inherent challenges.

Understanding Market Dynamics in the Phosphoramidite Market

The Phosphoramidite Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing demand for DNA and RNA oligonucleotides in research and therapeutic applications
    • Surging demand for personalized medicine solutions utilizing oligonucleotide synthesis
    • Expansion of the pharmaceutical and biotechnology industries
  • Market Restraints
    • High cost and scalability issues with phosphoramidite synthesis
  • Market Opportunities
    • Surge in government funding in biotechnology research
    • Ongoing collaborations and partnerships within biotech and pharmaceutical companies
  • Market Challenges
    • Environmental and safety concerns associated with phosphoramidite synthesis

Exploring Porter’s Five Forces for the Phosphoramidite Market

Porter’s Five Forces framework further strengthens the insights of the Phosphoramidite Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Phosphoramidite Market

External macro-environmental factors deeply influence the performance of the Phosphoramidite Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Phosphoramidite Market

The Phosphoramidite Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Phosphoramidite Market

The Phosphoramidite Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Phosphoramidite Market

The Phosphoramidite Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Phosphoramidite Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Actylis, Amadis Chemical Company Limited, American International Chemical, LLC by LeBaronBrown Industries LLC, Beijing SBS Genetech Co., Ltd., Bioneer Corporation, Biosynth Ltd., BOCSCI Inc., ChemGenes Corporation, Creative Biolabs, Inc., Hongene Biotech Corporation, Integrated DNA Technologies, Inc. by Danaher Corporation, LGC Genomics Limited, Lumiprobe Corporation, Maravai LifeSciences Holdings, Inc.,, MedChemExpress, Merck KGaA, PolyOrg, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co., Ltd., Twist Bioscience Corporation, and Wuhu Huaren Science and Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Phosphoramidite Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • DNA Phosphoramidites
    • Dye-Labeled Phosphoramidites
    • RNA Phosphoramidites
    • Speciality Phosphoramidites
  • Purity Level
    • High Purity
    • Standard Purity
  • End-User
    • Academic & Research Institutions
    • Contract Research Organizations
    • Diagnostic Laboratories
    • Pharmaceutical & Biotechnology
  • Application
    • Diagnostics Development
    • Drug Discovery & Development
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Phosphoramidite Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for oligonucleotides in genetic research, diagnostics, therapeutics, and biotechnology
5.1.1.2. Continuous advancements in genomics research with the advent of sequencing technologies
5.1.1.3. Expansion of the pharmaceutical and biotechnology industries
5.1.2. Restraints
5.1.2.1. High cost and scalability issues with phosphoramidite synthesis
5.1.3. Opportunities
5.1.3.1. Continuous advancements in synthesis methods and techniques for phosphoramidites
5.1.3.2. High potential owing to rising advancements in personalized medicine
5.1.4. Challenges
5.1.4.1. Environmental and safety concerns associated with phosphoramidite synthesis
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Phosphoramidite Market, by Type
6.1. Introduction
6.2. DNA Phosphoramidites
6.3. Dye-Labeled Phosphoramidites
6.4. RNA Phosphoramidites
6.5. Speciality Phosphoramidites
7. Phosphoramidite Market, by End-User
7.1. Introduction
7.2. Academic & Research Institutions
7.3. Contract Research Organizations
7.4. Pharmaceutical & Biotechnology
8. Americas Phosphoramidite Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Phosphoramidite Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Phosphoramidite Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
11.3.1. Agreement, Collaboration, & Partnership
11.3.1.1. Innovassynth and Actylis partner to address Nucleic Acid Supply Chain Vulnerabilities
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AAT Bioquest, Inc.
12.1.2. Actylis
12.1.3. Amadis Chemical Company Limited
12.1.4. American International Chemical, LLC
12.1.5. Bioneer Corporation
12.1.6. Biosynth Ltd.
12.1.7. BOCSCI Inc.
12.1.8. ChemGenes Corporation
12.1.9. Creative Biolabs
12.1.10. Hongene Biotech Corporation
12.1.11. Huaren Science and Technology Co., Ltd.
12.1.12. Integrated DNA Technologies, Inc. by Danaher Corporation
12.1.13. LGC Limited
12.1.14. Lumiprobe Corporation
12.1.15. Maravai LifeSciences
12.1.16. MedChemExpress
12.1.17. Merck KGaA
12.1.18. PolyOrg, Inc.
12.1.19. QIAGEN N.V.
12.1.20. SBS Genetech Co., Ltd.
12.1.21. STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd.
12.1.22. Thermo Fisher Scientific Inc.
12.1.23. Tokyo Chemical Industry Co., Ltd.
12.1.24. Twist Bioscience Corporation
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. PHOSPHORAMIDITE MARKET RESEARCH PROCESS
FIGURE 2. PHOSPHORAMIDITE MARKET SIZE, 2022 VS 2030
FIGURE 3. PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. PHOSPHORAMIDITE MARKET DYNAMICS
FIGURE 7. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 10. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. PHOSPHORAMIDITE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PHOSPHORAMIDITE MARKET SIZE, BY DNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PHOSPHORAMIDITE MARKET SIZE, BY DYE-LABELED PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PHOSPHORAMIDITE MARKET SIZE, BY RNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PHOSPHORAMIDITE MARKET SIZE, BY SPECIALITY PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 11. PHOSPHORAMIDITE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PHOSPHORAMIDITE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. CANADA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. CANADA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. CHINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. CHINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. INDIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. INDIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. ITALY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. ITALY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. POLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. POLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. QATAR PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. QATAR PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 101. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2022
TABLE 102. PHOSPHORAMIDITE MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the Phosphoramidite market, which are profiled in this report, include:
  • AAT Bioquest, Inc.
  • Actylis
  • Amadis Chemical Company Limited
  • American International Chemical, LLC by LeBaronBrown Industries LLC
  • Beijing SBS Genetech Co., Ltd.
  • Bioneer Corporation
  • Biosynth Ltd.
  • BOCSCI Inc.
  • ChemGenes Corporation
  • Creative Biolabs, Inc.
  • Hongene Biotech Corporation
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • LGC Genomics Limited
  • Lumiprobe Corporation
  • Maravai LifeSciences Holdings, Inc.,
  • MedChemExpress
  • Merck KGaA
  • PolyOrg, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • Twist Bioscience Corporation
  • Wuhu Huaren Science and Technology Co., Ltd.

Methodology

Loading
LOADING...

Table Information